PGHL

Procter & Gamble Health Financial Results

₹5,221.50-1.59%
Market cap
₹8,667 crore
P/E
24.3
P/B
16.52
ROE
61.5%
Dividend yield
1.72%

For the year ended Dec 2018, Procter & Gamble Health reported revenue of ₹849 crore and net profit of ₹839 crore, against ₹1,009 crore and ₹177 crore a year earlier.

Procter & Gamble Health annual profit and loss

Financial years, newest first. TTM = trailing twelve months.

Procter & Gamble Health annual profit and loss (₹ crore)
ItemDec 2018Jun 2021Jun 2022Jun 2023Jun 2024Mar 2026TTM
Revenue8491,0091,0921,2061,1291,3851,433
Expenses702763817882823927967
Operating profit147246275324307459466
Operating margin %17%24%25%27%27%33%33%
Other income3118619-51549
Interest0101111
Depreciation20302728272424
Profit before tax158233253314273450490
Tax %36%24%24%27%26%27%27%
Net profit839177193229201327357
EPS (₹)0.00106.51115.98138.24121.08196.94215.00
Dividend payout %———————

Source: Company filings (consolidated), in ₹ crore. Data as of 7 October 2026. How this data is compiled.

Procter & Gamble Health financial results — frequently asked questions

What is Procter & Gamble Health's annual revenue and net profit?

For the financial year ended Dec 2018, Procter & Gamble Health's revenue was ₹849 crore and net profit ₹839 crore; net profit rose 374.01% from ₹177 crore in Jun 2021.

How fast has Procter & Gamble Health grown over three years?

From Jun 2023 to Dec 2018, Procter & Gamble Health's revenue grew at a compound annual rate of -11.0% and net profit at 54.2%. Past growth does not indicate future results.

What is the EPS of Procter & Gamble Health?

Annual EPS for Dec 2018 was ₹0.00.

Are these figures consolidated or standalone?

They are consolidated figures as reported by the company, in ₹ crore. Trailing-twelve-month and half-year columns are labelled separately and are not counted as financial years.

Same Data For Peers

Trade Procter & Gamble Health With ATS

Track PGHL live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.

Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.